Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Target price


11:43 / Tradegate WKN: 659990 / Symbol: MKGAF / Name: Merck / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Merck KGaA Stock

A loss of -1.480% shows a downward development for Merck KGaA.
Our community is currently high on Merck KGaA with 3 Buy predictions and 1 Sell predictions.
However, we have a potential of -12.0% for Merck KGaA as the target price of 146 € is below the current price of 165.9 €.
For the coming years our community has positive and negative things to say abot the Merck KGaA stock. Criterium "Return on equity" gathered the most positive votes but regarding "Expected dividend yield" there were negative voices in the community.

Pros and Cons of Merck KGaA in the next few years

M***** P*******
W********* I********* f** t** n*** y****
G***** c******* t* c**********
C******** o* t** e**********
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Merck KGaA vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Merck KGaA -1.480% 0.537% 12.267% 2.092% 16.985% 14.208% 92.413%
Bayer AG 1.680% -4.240% -1.383% -50.120% -19.450% -48.233% -49.889%
Elanco Animal Health Inc. 1.290% 4.715% 27.422% 107.249% 19.260% -45.361% -
Pfizer Inc. 0.210% -5.811% 7.734% -26.894% -1.264% -18.886% -27.269%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-15

It appears that Merck, operating under the US symbol MKGAF, showcases stable financial performance within the pharmaceuticals industry. The company has shown consistent growth in total assets and net income in recent years, and its overall financial position and liquidity seem to be in good shape.

In conclusion, Merck's financials reveal a generally positive situation for the company, with growth in total assets, net income, and operating cash flows. However, certain areas, such as increased long-term debt, negative net tangible assets, and changes in net working capital necessitate careful monitoring. As an analyst, monitoring Merck's financial performance and management strategies will be crucial to ensure sustained growth and stability in the coming years.


Buy Merck KGaA
Show more

Buy Merck KGaA
Show more

Sell Merck KGaA
Show more


Merck (MRK) Q1 2024 Earnings Call Transcript:
Merck (MRK) Q1 2024 Earnings Call Transcript

Image source: The Motley Fool.

Merck (NYSE: MRK)Q1 2024 Earnings CallApr 25, 2024, 9:00 a.m. ET


Continue reading


Merck Paid $208 Million to Stop Its Drugs From Working. Here's Why That's Bullish.:
Merck Paid $208 Million to Stop Its Drugs From Working. Here's Why That's Bullish.

In biopharma, it sometimes makes sense for companies to spend a lot of money on buying or developing technical capabilities that seem to be counterproductive at first glance. For instance, on April

2 Dividend Stocks to Buy and Hold Forever:
2 Dividend Stocks to Buy and Hold Forever

Dividends can provide a steady stream of income to shareholders, but only if the dividend-paying company maintains or increases its payouts over the years. Unfortunately, not every dividend payer is